Association of genetically proxied PDE5 inhibition with measures of fertility, sexual behavior, and wellbeing

Researchers performed a two-sample Mendelian randomization analysis to investigate the associations between genetically proxied suppression of PDE5, a recognized pharmacological target for erectile dysfunction, fertility, subjective wellness, and sexual behavior.

LENZ rallies presbyopia awareness with eyecare professionals ahead of FDA submission

LENZ Therapeutics is clear on the benefits of pre-commercial marketing for its presbyopia eye drops, bolstered by positive Phase 3 news this week. The new

April 6, 2024

NIH issues a policy to widen access to medical products that emerge from government-funded research

After years of prodding, the National Institutes of Health has adopted a new policy requiring companies seeking licenses to sell medical products invented with government

January 14, 2025

Google Invests in Ubie to Advance Digital Health Generative AI

What You Should Know: – Ubie Inc., a Japanese health tech company, has announced a significant investment from Google in its latest funding round. –

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.